Drug · DIN 02446014
DILTIAZEM CD
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 9, 2024; first marketed October 6, 2015.
- Drug Identification Number (DIN)
- 02446014
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Diltiazem C08DB01
- Class
- Human
- Record last updated
- March 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DILTIAZEM HYDROCHLORIDE | 240 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 18, 2024: NOC 32552New Drug Submission (NDS) · Administrative: Licensing Agreement Between Two Manufacturers
- September 28, 2015: NOC 17332Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named DILTIAZEM CD
- DIN 02400421 · Marketed
- DIN 02400448 · Marketed
- DIN 02400456 · Marketed
- DIN 02400464 · Marketed
- DIN 02445999 · Marketed
- DIN 02446006 · Marketed
- DIN 02446022 · Marketed